ALLEROD, Denmark, Jan 30 (Reuters) - A play examining the meteoric rise of Danish weight-loss drug giant Novo Nordisk (NOVOb.CO), opens new tab will premiere on Saturday at a theatre outside ...

Scroll your phone for five minutes and you’ll see it. Celebrities shrinking overnight. Friends suddenly “not that hungry anymore.” Weight loss drugs have gone from something your doctor quietly ...

Bitcoin price struggles near the previously broken midpoint of a horizontal parallel channel at $87,787 on Monday. US-listed spot ETFs recorded an outflow of $1.33 billion last week, the ...

Novo Nordisk has had a difficult year as investors questioned the company's ability to translate its strides in pioneering GLP-1 drugs to financial gains. Scientists, however, say that Novo's medicine ...

To ensure safety of mariners using the Calabar-Bakassi channel, Nigeria has deployed three newly produced Electronic Navigational Charts (ENCs) validated by the International Centre for Electronic ...

Billboard has announced an upcoming shift in its chart tabulation that will give more weight to music streaming against album sales. Starting in January, the magazine and authoritative record of music ...

Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its "Metabolic Frontier 2030" strategy. The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on ...

Weight Loss Trends 2025: The biggest fitness trend of 2025 was simple — people chose routines that were easy, enjoyable, and stress-free. Strict diets and exhausting workout regimes took a backseat, ...

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

You won't find dumbbells or weight machines in the gym Sean Keogh runs. At Calisthenics Club Houston, it's all about training with body weight. "That's all we do," Keogh said — but that's enough to ...

ATLANTA -- An investigational quadruple receptor agonist led to a substantial reduction in total body weight with minimal gastrointestinal adverse effects and no observed muscle loss, according to a ...